AMILI

Last Updated: 31 Jan 2025

AMILI is a precision gut microbiome company based in Singapore, leveraging cutting-edge technology and regional expertise to develop innovative diagnostics, predictive algorithms, and microbiome-modifying interventions. Our consumer health arm, BIO & ME, offers personalized solutions through insights from our comprehensive database and proprietary analytics engine, PRIME. Additionally, AMILI operates Southeast Asia's first and only gut microbiome bank for clinical use and research, providing unparalleled opportunities for advancing scientific understanding and improving human health.

Country of registration	Singapore
Registration number	201922200N
Local SIC	21022: Manufacture of other biological products and preparations for human use
Incorporation date	10 Jul 2019
Company age	6 years 8 months
Official entity type	Private Limited Company
No. of officers	71

Contact

Address:

89 SCIENCE PARK DRIVE, #03-09, THE RUTHERFORD, Singapore 118261

Access Key Decision Makers

This is the legal entity page of AMILI. To access company info, company size, news , key makers’ emails, visit the profile pages above.

The largest company and people database for SEA & ANZ

Associated business (1)

AMILI
Singapore
View More
gut microbiome
gut microbiome testing
gut health
stool bank
faecal microbiota transplants
research and development
personalised probiotics
innovation
data
Manufacturing
Pharmaceuticals
AMILI is a precision gut microbiome company based in Singapore, leveraging cutting-edge technology and regional expertise to develop innovative diagnostics, predictive algorithms, and microbiome-modifying interventions. Our consumer health arm, BIO & ME, offers personalized solutions through insights from our comprehensive database and proprietary analytics engine, PRIME. Additionally, AMILI operates Southeast Asia's first and only gut microbiome bank for clinical use and research, providing unparalleled opportunities for advancing scientific understanding and improving human health.

This is the legal entity page of AMILI. To access company info, company size, news, key maker's emails, visit the profile pages above.

Financials

Auditor	ZHONGLEI SINGAPORE
Revenue	> 10m
Share Capital - Preference shares	USD 14,668,248
Share Capital - Ordinary shares	USD 2,594,625

Last updated: 31 Jan 2025

* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.

Discover More Companies

Lookalike companies

* This profile contains information from ACRA Information on Corporate Entities from Accounting and Corporate Regulatory Authority which is made available under the terms of the Singapore Open Data Licence version 1.0. Information and datasets on our website are provided on an “as is” and “as available” basis. This website makes no representations or warranties concerning the datasets, including but not limited to any representation or warranty as to the accuracy, completeness, reliability, continued availability, timeliness, non-infringement, title, quality, or fitness for any particular purpose of the datasets to the fullest extent permitted by the law.

Frequently Asked Questions (FAQ)

What is the address of AMILI?
Where is AMILI's headquarter?
What is AMILI's contact number?
What AMILI's spending power?
Does AMILI have a presence in the domain it operates in?